Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Anti-tumor effects of a human VEGFR-2-based DNA vaccine in mouse models.

    Xie K, Bai RZ, Wu Y, Liu Q, Liu K, Wei YQ.

    Genet Vaccines Ther. 2009 Jun 21;7:10.

    PMID:
    19545394
    [PubMed]
    Free PMC Article
    2.

    Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.

    Wang YS, Wang GQ, Wen YJ, Wang L, Chen XC, Chen P, Kan B, Li J, Huang C, Lu Y, Zhou Q, Xu N, Li D, Fan LY, Yi T, Wu HB, Wei YQ.

    Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6779-87.

    PMID:
    18006780
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.

    Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F.

    Blood. 2003 Sep 1;102(5):1815-23. Epub 2003 May 15.

    PMID:
    12750177
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.

    Wei YQ, Huang MJ, Yang L, Zhao X, Tian L, Lu Y, Shu JM, Lu CJ, Niu T, Kang B, Mao YQ, Liu F, Wen YJ, Lei S, Luo F, Zhou LQ, Peng F, Jiang Y, Liu JY, Zhou H, Wang QR, He QM, Xiao F, Lou YY, Xie XJ, Li Q, Wu Y, Ding ZY, Hu B, Hu M, Zhang W.

    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11545-50. Epub 2001 Sep 11.

    PMID:
    11553767
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models.

    Jiao JG, Li YN, Wang H, Liu Q, Cao JX, Bai RZ, Huang FY.

    Dig Liver Dis. 2006 Aug;38(8):578-87. Epub 2006 Jun 13.

    PMID:
    16777500
    [PubMed - indexed for MEDLINE]
    7.

    [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22].

    Lu F, Qin ZY, Li YM, Qi YX, Liu YF, Yang WB.

    Ai Zheng. 2004 Dec;23(12):1616-21. Chinese.

    PMID:
    15601548
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.

    Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.

    Clin Cancer Res. 2006 Nov 1;12(21):6573-84.

    PMID:
    17085673
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants.

    Heidenreich R, Machein M, Nicolaus A, Hilbig A, Wild C, Clauss M, Plate KH, Breier G.

    Int J Cancer. 2004 Sep 1;111(3):348-57.

    PMID:
    15221961
    [PubMed - indexed for MEDLINE]
    11.

    Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice.

    He QM, Wei YQ, Tian L, Zhao X, Su JM, Yang L, Lu Y, Kan B, Lou YY, Huang MJ, Xiao F, Liu JY, Hu B, Luo F, Jiang Y, Wen YJ, Deng HX, Li J, Niu T, Yang JL.

    J Biol Chem. 2003 Jun 13;278(24):21831-6. Epub 2003 Mar 21.

    PMID:
    12651849
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

    Ciardiello F, Caputo R, Damiano V, Caputo R, Troiani T, Vitagliano D, Carlomagno F, Veneziani BM, Fontanini G, Bianco AR, Tortora G.

    Clin Cancer Res. 2003 Apr;9(4):1546-56.

    PMID:
    12684431
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.

    Endo A, Fukuhara S, Masuda M, Ohmori T, Mochizuki N.

    J Recept Signal Transduct Res. 2003;23(2-3):239-54.

    PMID:
    14626450
    [PubMed - indexed for MEDLINE]
    14.

    Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.

    Kamstock D, Elmslie R, Thamm D, Dow S.

    Cancer Immunol Immunother. 2007 Aug;56(8):1299-309. Epub 2007 Feb 14.

    PMID:
    17502972
    [PubMed - indexed for MEDLINE]
    15.

    Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.

    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.

    Glycobiology. 2009 Mar;19(3):229-39. Epub 2008 Oct 30.

    PMID:
    18974200
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

    Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ.

    Cancer Res. 1999 Oct 15;59(20):5209-18.

    PMID:
    10537299
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.

    Oncogene. 2005 Jan 27;24(5):790-800. Erratum in: Oncogene. 2005 Jun 9;24(25):4164.

    PMID:
    15592523
    [PubMed - indexed for MEDLINE]
    18.

    Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.

    Rakhmilevich AL, Hooper AT, Hicklin DJ, Sondel PM.

    Mol Cancer Ther. 2004 Aug;3(8):969-76.

    PMID:
    15299079
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.

    Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K.

    Nature. 2008 Jul 31;454(7204):656-60. Epub 2008 Jun 25.

    PMID:
    18594512
    [PubMed - indexed for MEDLINE]
    20.

    Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant.

    Xu GL, Zhang KQ, Guo B, Zhao TT, Yang F, Jiang M, Wang QH, Shang YH, Wu YZ.

    Vaccine. 2010 Oct 18;28(44):7221-7. Epub 2010 Aug 25.

    PMID:
    20800113
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk